Support: 888-992-3836
Copyright © 2023 InvestorsHub Inc.
Replies to post #42 on MyMD Pharmaceuticals Inc (MYMD)
leifsmith
05/05/21 9:12 AM
#43 RE: knuts4oe #42
MYMD-1 improved the course of EAE and suppressed activation of effector T cells without causing global immunosuppression or toxicity. These results suggest that MYMD-1 may be of interest for evaluating for the treatment of autoimmune diseases.